# 180 Degree vs. 360 Degree Selective Laser Trabeculoplasty as Initial Therapy for Glaucoma

> **NCT02628223** · NA · COMPLETED · sponsor: **Temple University** · enrollment: 76 (actual)

## Conditions studied

- Open Angle Glaucoma
- Ocular Hypertension
- Glaucoma, Open Angle, Pseudo-exfoliative
- Pigment Dispersion Syndrome
- Glaucoma

## Interventions

- **PROCEDURE:** Selective Laser Trabeculoplasty
- **DEVICE:** Neodymium:Yttrium Aluminum Garnet (YAG) laser

## Key facts

- **NCT ID:** NCT02628223
- **Lead sponsor:** Temple University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-09
- **Primary completion:** 2017-12
- **Final completion:** 2017-12
- **Target enrollment:** 76 (ACTUAL)
- **Last updated:** 2020-11-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02628223

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02628223, "180 Degree vs. 360 Degree Selective Laser Trabeculoplasty as Initial Therapy for Glaucoma". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT02628223. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*